Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study

Detalles Bibliográficos
Autores principales: Hattori, Masaya, Ishiguro, Hiroshi, Masuda, Norikazu, Yoshimura, Akiyo, Ohtani, Shoichiro, Yasojima, Hiroyuki, Morita, Satoshi, Ohno, Shinji, Iwata, Hiroji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2017
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741781/
https://www.ncbi.nlm.nih.gov/pubmed/29159517
http://dx.doi.org/10.1007/s12282-017-0815-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741781/
https://www.ncbi.nlm.nih.gov/pubmed/29159517
http://dx.doi.org/10.1007/s12282-017-0815-7

Ejemplares similares